The Longtine Center for Neurodegenerative Biochemistry, Banner Sun Health Research Institute, Sun City, Arizona, United States of America.
PLoS One. 2011;6(11):e27291. doi: 10.1371/journal.pone.0027291. Epub 2011 Nov 7.
The amyloid cascade hypothesis provides an economical mechanistic explanation for Alzheimer's disease (AD) dementia and correlated neuropathology. However, some nonagenarian individuals (high pathology controls, HPC) remain cognitively intact while enduring high amyloid plaque loads for decades. If amyloid accumulation is the prime instigator of neurotoxicity and dementia, specific protective mechanisms must enable these HPC to evade cognitive decline. We evaluated the neuropathological and biochemical differences existing between non-demented (ND)-HPC and an age-matched cohort with AD dementia. The ND-HPC selected for our study were clinically assessed as ND and possessed high amyloid plaque burdens. ELISA and Western blot analyses were used to quantify a group of proteins related to APP/Aβ/tau metabolism and other neurotrophic and inflammation-related molecules that have been found to be altered in neurodegenerative disorders and are pivotal to brain homeostasis and mental health. The molecules assumed to be critical in AD dementia, such as soluble or insoluble Aβ40, Aβ42 and tau were quantified by ELISA. Interestingly, only Aβ42 demonstrated a significant increase in ND-HPC when compared to the AD group. The vascular amyloid load which was not used in the selection of cases, was on the average almost 2-fold greater in AD than the ND-HPC, suggesting that a higher degree of microvascular dysfunction and perfusion compromise was present in the demented cohort. Neurofibrillary tangles were less frequent in the frontal cortices of ND-HPC. Biochemical findings included elevated vascular endothelial growth factor, apolipoprotein E and the neuroprotective factor S100B in ND-HPC, while anti-angiogenic pigment epithelium derived factor levels were lower. The lack of clear Aβ-related pathological/biochemical demarcation between AD and ND-HPC suggests that in addition to amyloid plaques other factors, such as neurofibrillary tangle density and vascular integrity, must play important roles in cognitive failure.
淀粉样蛋白级联假说为阿尔茨海默病(AD)痴呆症和相关神经病理学提供了一种经济的机制解释。然而,一些 90 岁以上的个体(高病理对照,HPC)在数十年内持续承受高淀粉样斑块负荷的情况下保持认知完整。如果淀粉样蛋白积累是神经毒性和痴呆的主要引发因素,那么特定的保护机制必须使这些 HPC 能够避免认知能力下降。我们评估了非痴呆(ND)-HPC 与年龄匹配的 AD 痴呆症队列之间存在的神经病理学和生物化学差异。我们选择的 ND-HPC 经临床评估为 ND,并且具有高淀粉样斑块负担。ELISA 和 Western blot 分析用于定量一组与 APP/Aβ/tau 代谢相关的蛋白质以及其他已发现在神经退行性疾病中发生改变的神经营养和炎症相关分子,这些分子对大脑内稳态和心理健康至关重要。假设在 AD 痴呆症中起关键作用的分子,如可溶性或不溶性 Aβ40、Aβ42 和 tau,通过 ELISA 进行定量。有趣的是,与 AD 组相比,仅 Aβ42 在 ND-HPC 中表现出显著增加。血管淀粉样蛋白负荷在病例选择中未使用,AD 组比 ND-HPC 组平均高近 2 倍,表明痴呆组存在更高程度的微血管功能障碍和灌注受损。ND-HPC 额皮质中的神经原纤维缠结较少。生化发现包括血管内皮生长因子、载脂蛋白 E 和神经保护因子 S100B 的升高,而抗血管生成色素上皮衍生因子水平较低。AD 和 ND-HPC 之间缺乏明确的 Aβ 相关病理/生化界限表明,除了淀粉样斑块外,其他因素,如神经原纤维缠结密度和血管完整性,也必须在认知失败中发挥重要作用。